211 related articles for article (PubMed ID: 23353033)
1. Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis.
Petrella C; Giuli C; Broccardo M; Eutamene H; Cartier C; Leveque M; Bedini A; Spampinato S; Bueno L; Theodorou V; Improta G; Agostini S
Pharmacol Res; 2013 Apr; 70(1):72-9. PubMed ID: 23353033
[TBL] [Abstract][Full Text] [Related]
2. Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats.
Agostini S; Eutamene H; Broccardo M; Improta G; Petrella C; Theodorou V; Bueno L
Pain; 2009 Feb; 141(3):292-299. PubMed ID: 19147291
[TBL] [Abstract][Full Text] [Related]
3. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
4. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
[TBL] [Abstract][Full Text] [Related]
5. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
[TBL] [Abstract][Full Text] [Related]
7. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.
Thomas RC; Bath MF; Stover CM; Lambert DG; Thompson JP
Peptides; 2014 Nov; 61():56-60. PubMed ID: 25161013
[TBL] [Abstract][Full Text] [Related]
8. Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon.
Grandi D; Massi M; Guerrini R; Caló G; Morini G
Life Sci; 2011 Nov; 89(19-20):735-40. PubMed ID: 21925513
[TBL] [Abstract][Full Text] [Related]
9. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245
[TBL] [Abstract][Full Text] [Related]
10. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
[TBL] [Abstract][Full Text] [Related]
11. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
12. The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
Brookes ZL; Stedman EN; Brown NJ; Hebbes CP; Guerrini R; Calo G; Reilly CS; Lambert DG
PLoS One; 2013; 8(9):e74943. PubMed ID: 24086402
[TBL] [Abstract][Full Text] [Related]
13. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
[TBL] [Abstract][Full Text] [Related]
14. The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions.
Broccardo M; Guerrini R; Morini G; Polidori C; Agostini S; Petrella C; Improta G
Peptides; 2007 Oct; 28(10):1974-81. PubMed ID: 17765363
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis.
Alt C; Lam JS; Harrison MT; Kershaw KM; Samuelsson S; Toll L; D'Andrea A
Eur J Pharmacol; 2012 May; 683(1-3):285-93. PubMed ID: 22449384
[TBL] [Abstract][Full Text] [Related]
17. Roles of nociceptin/orphanin FQ and nociceptin/orphanin FQ peptide receptor in respiratory rhythm generation in the medulla oblongata: an in vitro study.
Takita K; Morimoto Y; Kemmotsu O
Br J Anaesth; 2003 Sep; 91(3):385-9. PubMed ID: 12925479
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia.
Scoto GM; Aricò G; Ronsisvalle S; Parenti C
Peptides; 2007 Jul; 28(7):1441-6. PubMed ID: 17628212
[TBL] [Abstract][Full Text] [Related]
19. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D
CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234
[TBL] [Abstract][Full Text] [Related]
20. Nociceptin/orphanin FQ prevents gastric damage induced by cold-restraint stress in the rat by acting in the periphery.
Grandi D; Solenghi E; Guerrini R; Polidori C; Massi M; Morini G
Peptides; 2007 Aug; 28(8):1572-9. PubMed ID: 17651865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
